Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Videos | Atrial Fibrillation

Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of ...

Home June 21, 2019
Home
News | Patient Engagement

June 17, 2019 โ€“ Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical ...

Home June 17, 2019
Home
News | Pharmaceuticals

June 14, 2019 โ€” Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...

Home June 14, 2019
Home
News | Left Atrial Appendage (LAA) Occluders

June 12, 2019 โ€” Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next ...

Home June 12, 2019
Home
News | Pharmaceuticals

May 29, 2019 โ€” Amarin Corp. plc announced that its supplemental new drug application (sNDA) for Vascepa (icosapent ethyl ...

Home May 29, 2019
Home
Technology | Antiplatelet and Anticoagulation Therapies

May 17, 2019 โ€” The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...

Home May 17, 2019
Home
Technology | Heart Failure

May 6, 2019 โ€” The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis ...

Home May 06, 2019
Home
Technology | Antiplatelet and Anticoagulation Therapies

April 30, 2019 โ€” PhaseBio Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has granted ...

Home April 30, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 24, 2019 โ€” New research from the University of Illinois at Chicago shows that when pharmacies close, people stop ...

Home April 24, 2019
Home
News | Heart Failure

April 19, 2019 โ€“ Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that the recently ...

Home April 19, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 18, 2019 โ€” A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...

Home April 18, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 16, 2019 โ€” HonorHealth Research Institute announced the first patients have been enrolled in the SynIVUS-DAPT ...

Home April 16, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

April 15, 2019 โ€” Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients ...

Home April 15, 2019
Home
News | Heart Failure

March 29, 2019 โ€” The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...

Home March 29, 2019
Home
Subscribe Now